Adipokines and cytokines in non-alcoholic fatty liver disease

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 2, 2008, Pages 266-267

  Tasci, I ^a   Dogru, T ^a   Ercin, C N ^a   Erdem, G ^a   Sonmez, A ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; GLUCOSE; INSULIN;

BLOOD PRESSURE; BODY MASS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STEATOSIS;

ADIPOKINES; BLOOD GLUCOSE; CONFOUNDING FACTORS (EPIDEMIOLOGY); FATTY LIVER; HUMANS; INSULIN RESISTANCE;

EID: 45549110241     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03697.x     Document Type: Letter

References (7)

1. Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008 27 : 412 21.
2. Dogru T, Sonmez A, Tasci I, et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007 76 : 24 9.
3. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006 91 : 295 9.
4. Watanabe S, Okura T, Kurata M, et al. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Clin Ther 2006 28 : 1677 85.
5. Tasci I, Dogru T, Naharci I, et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes 2007 115 : 428 32.
6. Riera-Guardia N, Rothenbacher D. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab 2007 21 (Epub ahead of print).
7. Kim HJ, Kang ES, Kim DJ, et al. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Clin Endocrinol 2007 66 : 282 9.